Stereotactic Body Radiotherapy for Oligometastasis
Anand Mahadevan, Nergiz R. Dagoglu
core +1 more source
Immunotherapy and local therapies in metastatic laryngeal cancer management: a case report. [PDF]
Lima Feldmann JF +6 more
europepmc +1 more source
Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. <i>Cancers</i> 2025, <i>17</i>, 1120. [PDF]
Miyajima Y, Kawakami T.
europepmc +1 more source
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET Era. [PDF]
Bhandari M +9 more
europepmc +1 more source
Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era. [PDF]
Sittiwong W +6 more
europepmc +1 more source
Oligometastatic Prostate Cancer: Clues from an N-of-1. [PDF]
Kirschenbaum A +7 more
europepmc +1 more source
Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapy. [PDF]
Lin Q, Zhou Y, Guo LF, Lu GZ, Wu SG.
europepmc +1 more source
Clinical utility of the ESTRO-EORTC classification in oligometastatic disease treated with stereotactic body radiotherapy: a single-institution retrospective study. [PDF]
Goto M +7 more
europepmc +1 more source
Skull Base Metastases: A Pictorial Review. [PDF]
Heyworth A, van Camp L.
europepmc +1 more source

